eFFECTOR Therapeutics (EFTR) Stock Chart & Stock Price History $0.0004 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends eFFECTOR Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance-98.42%3 Month Performance-99.12%6 Month Performance-99.98%Year-To-Date Performance-100.00%1 Year Performance-100.00% Receive EFTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link EFTR Stock Chart for Tuesday, November, 5, 2024 EFTR Chart by TradingView eFFECTOR Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$0.00$0.00$0.00$0.00373 shs$2,000.0011/01/2024$0.00$0.00$0.00$0.00415 shs$2,000.0010/31/2024$0.00$0.00$0.00$0.002,120 shs$2,000.0010/30/2024$0.00$0.00$0.00$0.002,120 shs$2,000.0010/29/2024$0.00$0.00+33.33%$0.00$0.005,053 shs$2,000.0010/28/2024N/A$0.00$0.00$0.002,238 shs$1,000.00 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$0.00$0.00-91.67%$0.00$0.00156 shs$0.0010/24/2024$0.00$0.00$0.00$0.0025,854 shs$6,000.0010/23/2024$0.00$0.00$0.00$0.002,584 shs$6,000.0010/22/2024$0.00$0.00$0.00$0.0031,480 shs$6,000.0010/21/2024$0.00$0.00$0.00$0.003,787 shs$6,000.0010/18/2024$0.00$0.00+9.09%$0.00$0.0012,209 shs$6,000.0010/17/2024$0.00$0.00$0.00$0.00282,428 shs$5,000.0010/16/2024$0.03$0.00-96.61%$0.04$0.0021,277 shs$5,000.0010/15/2024$0.03$0.03+1.41%$0.04$0.0379,165 shs$153,000.0010/14/2024$0.03$0.03+27.49%$0.04$0.0323,454 shs$151,000.0010/11/2024$0.03$0.03$0.04$0.0315,975 shs$132,000.0010/10/2024$0.04$0.03-25.33%$0.03$0.0315,975 shs$132,000.0010/09/2024$0.04$0.04-6.25%$0.04$0.03984 shs$176,000.0010/08/2024$0.04$0.04$0.04$0.0312,605 shs$188,000.0010/07/2024$0.03$0.04+58.10%$0.04$0.0322,128 shs$188,000.0010/04/2024$0.04$0.03-27.71%$0.04$0.0311,037 shs$119,000.0010/03/2024$0.03$0.04+16.28%$0.04$0.0310,661 shs$165,000.0010/02/2024$0.04$0.03-24.75%$0.04$0.0319,064 shs$142,000.0010/01/2024$0.04$0.04+8.11%$0.04$0.0415,190 shs$188,000.0009/30/2024$0.04$0.04-5.13%$0.04$0.0458,464 shs$174,000.0009/27/2024$0.04$0.04+5.41%$0.04$0.0412,372 shs$183,000.0009/26/2024$0.05$0.04-17.78%$0.05$0.04172,889 shs$174,000.0009/25/2024$0.04$0.05+12.50%$0.05$0.048,618 shs$212,000.0009/24/2024$0.04$0.04-2.44%$0.05$0.0479,872 shs$188,000.0009/23/2024$0.04$0.04-5.20%$0.04$0.041,642 shs$193,000.0009/20/2024$0.04$0.04+1.88%$0.05$0.047,743 shs$204,000.0009/19/2024$0.04$0.04+6.25%$0.05$0.0424,554 shs$200,000.0009/18/2024$0.05$0.04-14.89%$0.05$0.04159,088 shs$188,000.0009/17/2024$0.04$0.05+17.50%$0.05$0.0412,312 shs$221,000.0009/16/2024$0.05$0.04-15.79%$0.05$0.043,983 shs$188,000.0009/13/2024$0.04$0.05+18.75%$0.06$0.0417,355 shs$223,000.0009/12/2024$0.04$0.04$0.06$0.0482,925 shs$188,000.0009/11/2024$0.04$0.04$0.05$0.0416,651 shs$188,000.0009/10/2024$0.04$0.04$0.04$0.042,115 shs$188,000.00Top 10 AI Stocks to Buy Now (Ad)Are you ready to capitalize on the booming AI market? Our experts have identified the top 10 AI stocks set to skyrocket.Download our free report today09/09/2024$0.04$0.04$0.05$0.042,643 shs$188,000.0009/06/2024$0.04$0.04$0.05$0.0415,261 shs$188,000.0009/05/2024$0.04$0.04+14.29%$0.05$0.03190,340 shs$188,000.0009/04/2024$0.04$0.04-12.50%$0.04$0.0341,322 shs$165,000.0009/03/2024$0.04$0.04$0.04$0.04301 shs$188,000.0009/02/2024$0.04$0.04$0.05$0.037,600 shs$188,000.0008/30/2024$0.03$0.04+29.03%$0.05$0.037,693 shs$188,000.0008/29/2024$0.05$0.03-31.11%$0.05$0.03333,683 shs$146,000.0008/28/2024$0.05$0.05-7.79%$0.05$0.053,020 shs$212,000.0008/27/2024$0.05$0.05+2.52%$0.05$0.054,690 shs$230,000.0008/26/2024$0.05$0.05-2.36%$0.05$0.0512,106 shs$224,000.0008/23/2024$0.05$0.05+8.44%$0.05$0.051,553 shs$230,000.0008/22/2024$0.05$0.05-5.51%$0.05$0.0510,653 shs$212,000.0008/21/2024$0.05$0.05-4.75%$0.05$0.05155,614 shs$224,000.0008/20/2024$0.05$0.05$0.05$0.0562,555 shs$235,000.0008/19/2024$0.05$0.05+0.10%$0.05$0.0574,949 shs$235,000.0008/16/2024$0.05$0.05+2.88%$0.05$0.058,185 shs$235,000.0008/15/2024$0.05$0.05+3.40%$0.06$0.0510,461 shs$229,000.0008/14/2024$0.05$0.05-11.82%$0.06$0.0539,844 shs$221,000.0008/13/2024$0.05$0.05+1.52%$0.05$0.0511,672 shs$251,000.0008/12/2024$0.05$0.05+10.53%$0.06$0.0566,215 shs$247,000.0008/09/2024$0.05$0.05+5.56%$0.05$0.055,343 shs$223,000.0008/08/2024$0.05$0.05-10.00%$0.05$0.059,050 shs$212,000.0008/07/2024$0.04$0.05+23.46%$0.05$0.0442,038 shs$235,000.0008/06/2024$0.05$0.04-10.93%$0.05$0.0444,349 shs$191,000.0008/05/2024$0.04$0.05+8.26%$0.05$0.03103,193 shs$214,000.00 Related Companies Comera Life Sciences Stock Price Chart Genocea Biosciences Stock Price Chart Genocea Biosciences Stock Price Chart Evelo Biosciences Stock Price Chart Ampio Pharmaceuticals Stock Price Chart 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EFTR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.